Home>>Signaling Pathways>> TGF-β / Smad Signaling>> Bcr-Abl>>PD 180970

PD 180970

Catalog No.GC12637

P210bcr/abl tyrosine kinase inhibitor

Products are for research use only. Not for human use. We do not sell to patients.

PD 180970 Chemical Structure

Cas No.: 287204-45-9

Size Price Stock Qty
1mg
$23.00
Ship Within 7 Days
5mg
$99.00
Ship Within 7 Days
10mg
$162.00
Ship Within 7 Days

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
ATP-competitive inhibitor of p210bcr/abl tyrosine kinase; selectively induces apoptosis in chronic myeloid leukemia (CML) K562 cells. Inhibits in vivo tyrosine phosphorylation of Gab2, CrkL and p210bcr/abl (IC50 values are 80, 80 and 170 nM respectively).

Reviews

Review for PD 180970

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PD 180970

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.